74 related articles for article (PubMed ID: 23495195)
21. Lack of cardiotoxicity of a new antineoplastic agent, a synthetic derivative of indenoisochinoline: comparison with daunorubicin in rabbits.
Gersl V; Mazurová Y; Bajgar J; Mĕlka M; Hrdina R; Palicka V
Arch Toxicol; 1996; 70(10):645-51. PubMed ID: 8870958
[TBL] [Abstract][Full Text] [Related]
22. Analysis of the substrate-binding site of human carbonyl reductases CBR1 and CBR3 by site-directed mutagenesis.
El-Hawari Y; Favia AD; Pilka ES; Kisiela M; Oppermann U; Martin HJ; Maser E
Chem Biol Interact; 2009 Mar; 178(1-3):234-41. PubMed ID: 19061875
[TBL] [Abstract][Full Text] [Related]
23. Carbonyl reduction of mequindox by chicken and porcine cytosol and cloned carbonyl reductase 1.
Tang X; Mu P; Wu J; Jiang J; Zhang C; Zheng M; Deng Y
Drug Metab Dispos; 2012 Apr; 40(4):788-95. PubMed ID: 22266778
[TBL] [Abstract][Full Text] [Related]
24. Purification and characterization of akr1b10 from human liver: role in carbonyl reduction of xenobiotics.
Martin HJ; Breyer-Pfaff U; Wsol V; Venz S; Block S; Maser E
Drug Metab Dispos; 2006 Mar; 34(3):464-70. PubMed ID: 16381663
[TBL] [Abstract][Full Text] [Related]
25. Central composite design as a powerful optimisation technique for enantioresolution of the rac-11-dihydrooracin--the principal metabolite of the potential cytostatic drug oracin.
Wsól V; Fell AF
J Biochem Biophys Methods; 2002 Dec; 54(1-3):377-90. PubMed ID: 12543513
[TBL] [Abstract][Full Text] [Related]
26. Synthesis of cytotoxic indenoisoquinoline topoisomerase I poisons.
Strumberg D; Pommier Y; Paull K; Jayaraman M; Nagafuji P; Cushman M
J Med Chem; 1999 Feb; 42(3):446-57. PubMed ID: 9986716
[TBL] [Abstract][Full Text] [Related]
27. Activity, stereospecificity, and stereoselectivity of microsomal enzymes in dependence on storage and freezing of rat liver samples.
Skálová L; Szotáková B; Wsól V; Král R; Baliharová V; Lamka J
Chirality; 2000 Oct; 12(9):649-53. PubMed ID: 10984737
[TBL] [Abstract][Full Text] [Related]
28. The effectiveness of oracin in enhancing the cytotoxicity of doxorubicin through the inhibition of doxorubicin deactivation in breast cancer MCF7 cells.
Hanusová V; Králová V; Schröterová L; Trilecová L; Pakostová A; Skálová L
Xenobiotica; 2010 Oct; 40(10):681-90. PubMed ID: 20698750
[TBL] [Abstract][Full Text] [Related]
29. Effect of the anticancer drug oracin on mouse liver topoisomerases I and II.
Stuchlík S; Turna J; Miko M
J Pharm Pharmacol; 2005 May; 57(5):657-9. PubMed ID: 15901355
[TBL] [Abstract][Full Text] [Related]
30. Use of rat hepatocytes immobilized in agarose gel threads for biosynthesis of metabolites of potential cytostatics.
Trejtnar F; Skálová L; Szotáková B; Wsól V
Exp Toxicol Pathol; 1999 Jul; 51(4-5):432-5. PubMed ID: 10445411
[TBL] [Abstract][Full Text] [Related]
31. [Purification of vancomycin by using magnetic affinity technique].
Guo LA; Zhu BQ; Chen DJ
Sheng Wu Gong Cheng Xue Bao; 2001 Sep; 17(5):584-6. PubMed ID: 11797227
[TBL] [Abstract][Full Text] [Related]
32. Preparation of convection interaction media isobutyl disc monolithic column and its application to purification of secondary alcohol dehydrogenase and alcohol oxidase.
Isobe K; Kawakami Y
J Chromatogr A; 2007 Mar; 1144(1):85-9. PubMed ID: 17113587
[TBL] [Abstract][Full Text] [Related]
33. High performance liquid affinity chromatography (HPLAC) and its application to the separation of enzymes and antigens.
Ohlson S; Hansson L; Larsson PO; Mosbach K
FEBS Lett; 1978 Sep; 93(1):5-9. PubMed ID: 212311
[No Abstract] [Full Text] [Related]
34. Tris(hydroxymethyl)aminomethane-modified magnetic microspheres for rapid affinity purification of lysozyme.
Zhang G; Cao Q; Li N; Li K; Liu F
Talanta; 2011 Feb; 83(5):1515-20. PubMed ID: 21238746
[TBL] [Abstract][Full Text] [Related]
35. Specific DNA G-quadruplexes bind to ethanolamines.
Cheng X; Liu X; Bing T; Zhao R; Xiong S; Shangguan D
Biopolymers; 2009 Oct; 91(10):874-83. PubMed ID: 19582835
[TBL] [Abstract][Full Text] [Related]
36. Purification and properties of carbonyl reductase from rabbit kidney.
Imamura Y; Higuchi T; Nozaki Y; Sugino E; Hibino S; Otagiri M
Arch Biochem Biophys; 1993 Feb; 300(2):570-6. PubMed ID: 8382027
[TBL] [Abstract][Full Text] [Related]
37. The influence of oracin on reduction and toxicity of doxorubicin in hepatocytes and mammary epithelial cells MCF-10A.
Hanušová V; Boušová I; Pakostová A; Skálová L
Xenobiotica; 2012 Jun; 42(6):571-9. PubMed ID: 22217270
[TBL] [Abstract][Full Text] [Related]
38. Analysis of the structure-anticancer activity relationship in a set of Schiff bases of macrocyclic 2,6-bis(2- and 4-formylaryloxymethyl)pyridines.
Kuz'min VE; Lozitsky VP; Kamalov GL; Lozitskaya RN; Zheltvay AI; Fedtchouk AS; Kryzhanovsky DN
Acta Biochim Pol; 2000; 47(3):867-75. PubMed ID: 11310986
[TBL] [Abstract][Full Text] [Related]
39. Nucleotide-mimetic synthetic ligands for DNA-recognizing enzymes One-step purification of Pfu DNA polymerase.
Melissis S; Labrou NE; Clonis YD
J Chromatogr A; 2006 Jul; 1122(1-2):63-75. PubMed ID: 16712859
[TBL] [Abstract][Full Text] [Related]
40. Chinese hamster monomeric carbonyl reductases of the short-chain dehydrogenase/reductase superfamily.
Miura T; Nishinaka T; Takama M; Murakami M; Terada T
Chem Biol Interact; 2009 Mar; 178(1-3):110-6. PubMed ID: 18983989
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]